(Q51905659)

17 April 2018

title

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment. (English)

1 reference

17 April 2018

mild cognitive impairment

0 references

1 reference

1 reference

1

1 reference

17 April 2018

Henrik Zetterberg

series ordinal

2

object named as

Henrik Zetterberg

1 reference

17 April 2018

7

Kaj Blennow

1 reference

17 April 2018

5

Elisabet Londos

1 reference

17 April 2018

6

Lennart Minthon

1 reference

17 April 2018

4

Ulf Andreasson

1 reference

17 April 2018

Peder Buchhave

series ordinal

3

object named as

Peder Buchhave

1 reference

17 April 2018

publication date

19 March 2007

1 reference

17 April 2018

Dementia and Geriatric Cognitive Disorders

published in

1 reference

17 April 2018

volume

23

1 reference

17 April 2018

issue

5

1 reference

17 April 2018

page(s)

316-320

1 reference

17 April 2018

1 reference

CSF markers for incipient Alzheimer's disease

21 January 2018

1 reference

APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42.

21 January 2018

1 reference

CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study

21 January 2018

1 reference

Age-dependent change in the levels of Abeta40 and Abeta42 in cerebrospinal fluid from control subjects, and a decrease in the ratio of Abeta42 to Abeta40 level in cerebrospinal fluid from Alzheimer's disease patients.

21 January 2018

1 reference

Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.

21 January 2018

1 reference

Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.

21 January 2018

1 reference

Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same?

21 January 2018

1 reference

Combination assay of CSF tau, A beta 1-40 and A beta 1-42(43) as a biochemical marker of Alzheimer's disease

21 January 2018

1 reference

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay.

21 January 2018

1 reference

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000100926

1 reference

17 April 2018

1 reference

17 April 2018